1. Blue Belt Technologies receives CE Mark for STRIDE

Written by Staff | Thursday, 29 January 2015 00:00
Minneapolis-based Blue Belt Technologies annouced in a press release that their STRIDETM Unicondylar Knee System received CE Mark.
X-Bolt Orthopaedics, an Ireland-based medical device company, received a U.S. patent for its alignment jig device used in its hip nailing system, according to a Business and Leadership report.
DePuy Synthes parent company Johnson & Johnson reported $18.3 billion in fourth quarter net sales — relatively flat over the same time last year — but full year sales reached $74.3 million, a 4.2 percent increase over the same period last year.

4. Stryker opens European headquarters — 5 quick facts

Written by Laura Dyrda | Thursday, 29 January 2015 00:00
Stryker will open its new European Regional Headquarters to support business overseas, according to Today's Medical Development.
Neel Anand, MD, a clinical professor of surgery and director of spine trauma at Cedars-Sinai Medical Center in Los Angeles, was featured in a HealthBeat report discussing spinal surgery.

6. Zimmer 4Q sales drop 1.4% — 10 things to know

Written by Laura Dyrda | Thursday, 29 January 2015 00:00
Zimmer beat expectations for fourth quarter profit, but net sales decreased 1.4 percent over the previous year.
Aesculap Implant Systems has received FDA 510(k) clearance for its Aesculap Odontoid Fracture Fixation System.
Blue Belt Technologies received the CE Mark for its STRIDE Unicondylar Knee System.

9. 5 observations on global neurostimulation device market

Written by Anuja Vaidya | Wednesday, 28 January 2015 00:00
Here are five insights from a new Kalorama Information Report into the global neurostimulation device market:
Stryker's 2014 earnings were down and missed expectations, but Chairman and CEO Kevin Lobo isn't panicking yet.

11. OrthAlign grew 46% in 2014 — 5 things to know

Written by Laura Dyrda | Wednesday, 28 January 2015 00:00
OrthAlign exceeded total 2014 sales forecasts. 
Medtronic finalized the acquisition for Covidien yesterday, after several months of waiting for regulatory approval.
Columbus-based The Ohio State University Wexner Medical Center announced the first U.S. implantation of a plastic device to help patients with injured or deteriorating meniscus cartilage.
EOS imaging announced that the FDA cleared its Micro Dose feature for pediatric imaging.
The spine industry has experienced a Renaissance period for the past few decades where innovation truly disrupted the old open spine surgeries of the past, making procedures less risky and painful. Advancement in fusion technology, motion preservation and less invasive procedures dominated recent advancements and additional biologic and regenerative solutions could be on the horizon.

16. 7 key updates on the robotic medical technology market

Written by Laura Dyrda | Tuesday, 27 January 2015 00:00
The global medical robotics market is expected to grow tremendously over the next several years, according to a new Reporterlink analysis.
Despite the 2.3 percent medical device excise tax used to fund the Patient Protection and Affordable Care Act, orthopedic device companies in Warsaw, Ind., are still hiring, according to a NewsOK report.

18. Dymicron's cervical TDR device receives CE Mark approval

Written by Anuja Vaidya | Monday, 26 January 2015 00:00
Dymicron announced that its Triadyme-C Cervical Total Disc Replacement device has earned the CE mark.
OrthAlign announced that more than 25,000 KneeAlign Total Knee Arthroplasty cases have been successfully completed, worldwide, thus far.
The Irish High Court approved Medtronic's pending acquisition of Ireland-based Covidien.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 187